Journal
INFECTION AND DRUG RESISTANCE
Volume 14, Issue -, Pages 5017-5026Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/IDR.S328261
Keywords
mode of action; efficacy; TCM; antivirals; COVID-19; respiratory pneumonia
Categories
Ask authors/readers for more resources
COVID-19 is a severe respiratory disorder caused by coronavirus, and there is currently no specific antiviral drug. 85% of patients in China are treated with traditional Chinese medicine, which has shown advantages in treating SARS-CoV.
COVID-19 is a pandemic and a serious respiratory disorder that is caused by coronavirus. It has produced an outbreak of acute infectious pneumonia in China and afterward all around the world. There is not a single anti-viral drug, vaccine or any kind of treatment available for this fatal disease. There are only a few options available for symptomatic relief. Thus, in China, 85% of SARS-CoV-2 infected individuals have been treated with traditional Chinese medicines (TCM). Thus, this article focused on the previous kinds of literature regarding COVID-19 and its treatment with TCM along with its applica-tions. SARS-CoV-2 and SARS-CoV showed similarity in genes, pathological processes, and epidemiology, so these can be treated with TCM. The proof regarding treatment of SARS-CoV with TCM explicitly shows the advantages of using TCM therapy for COVID-19. Present literature explains the mode of action and efficacy of TCM and elaborates on the natural compounds introduced to treat COVID-19.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available